Hedia

About Hedia

Hedia ApS is a digital health company operating in the diabetes management market, founded in Copenhagen, Denmark, in 2015. The company's creation was driven by a personal need after co-founder Peter Lucas was diagnosed with type 1 diabetes at age 27, the same age as his father's diagnosis. This firsthand experience with the daily challenges of the condition motivated Lucas, along with co-founders Christina Kildentoft and Andreas Jespensgaard, to develop a solution to simplify diabetes management.

Hedia has developed the Hedia Diabetes Assistant (HDA), a CE-marked, Class IIb medical device software application designed for individuals with insulin-requiring type 1 or type 2 diabetes. The application serves as a personal assistant, providing AI-powered insulin dosage recommendations. Its core functionality includes a bolus calculator that considers carbohydrate intake, physical activity, current glucose levels, and active insulin to suggest dosages. The app features a food library with over 1,500 items for carb counting, a logbook for tracking glucose levels, and connectivity with various blood glucose meters and smart insulin pens. The product is available in 11 countries and is accessed through healthcare professionals, clinics, or insurance providers.

The company's business model leverages partnerships with healthcare providers, clinics, hospitals, and pharmaceutical companies. Revenue is generated through a freemium model for the app, offering premium features via subscriptions, and by licensing the platform to healthcare systems. A key strategic partnership was formed with Glooko in January 2025 to integrate Hedia's insulin dosing technology with Glooko's remote monitoring platform. Since its first funding round in May 2018, Hedia has raised approximately $17.8 million over seven rounds, including a €3 million seed extension in February 2024 to support commercialization and expansion into European and US markets.